AI Terminal
PROCESSING_QUERY...
HIKMA Pharmaceuticals PLC
Director's Dealing • Mar 7, 2022
4841_dirs_2022-03-07_fad5a558-6bd7-4e2b-a2c2-b48c77f4a6ad.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8971D
Hikma Pharmaceuticals Plc
07 March 2022
Hikma Pharmaceuticals PLC - EIP B Vesting
LONDON, 7 March 2022: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 27 February 2020 under the 2014 Executive Incentive Plan ("EIP") Element B. The vesting process was completed on 4 March 2022.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Said Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Chairman |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. All Shares were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 47,169 |
| d) | Aggregated information - Volume - Price - Total |
47,169 £0.00 £0.00 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Siggi Olafsson
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Sigurdur Olafsson |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Executive Officer |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. 20,298 Shares were sold to cover tax and the remainder were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 32,850 Price(s): £19.57 Volume(s): 20,298 |
| d) | Aggregated information - Volume - Price - Total |
53,148 £19.57 £397,231.86 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Mazen Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Mazen Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Vice Chairman |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. All Shares were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 32,993 |
| d) | Aggregated information - Volume - Price Total |
32,993 £0.00 £0.00 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Riad Mishlawi
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Riad Mishlawi |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. All Shares were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 27,086 |
| d) | Aggregated information - Volume - Price - Total |
27,086 £0.00 £0.00 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Majda Labadi
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Majda Labadi |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. All Shares were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 14,211 |
| d) | Aggregated information - Volume - Price - Total |
14,211 £0.00 £0.00 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Bassam Kanaan
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Bassam Kanaan |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. All Shares were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 22,610 |
| d) | Aggregated information - Volume - Price - Total |
22,610 £0.00 £0.00 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Khalid Nabilsi
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Khalid Nabilsi |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. All Shares were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 22,709 |
| d) | Aggregated information - Volume - Price - Total |
22,709 £0.00 £0.00 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Brian Hoffmann
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Brian Hoffmann |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. 5,516 Shares were sold to cover tax and the remainder were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 8,925 Price(s): £19.57 Volume(s): 5,516 |
| d) | Aggregated information - Volume - Price - Total |
14,441 £19.57 £107,948.12 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Susan Ringdal
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Susan Ringdal |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. 5,550 Shares were sold to cover tax and the remainder were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 6,199 Price(s): £19.57 Volume(s): 5,550 |
| d) | Aggregated information - Volume - Price - Total |
11,749 £19.57 £108,613.50 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Henriette Nielsen
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Henriette Nielsen |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. 5,972 Shares were sold to cover tax and the remainder were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 9,663 Price(s): £19.57 Volume(s): 5,972 |
| d) | Aggregated information - Volume - Price - Total |
15,635 £19.57 £116,872.04 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Shahin Fesharaki
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Shahin Fesharaki |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. 2,961 Shares were sold to cover tax and the remainder were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 4,791 Price(s): £19.57 Volume(s): 2,961 |
| d) | Aggregated information - Volume - Price - Total |
7,752 £19.57 £57,946.77 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Hussein Arkhagha
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Hussein Arkhagha |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on 28 February 2022 under the EIP Element B. All Shares were retained. |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 11,308 |
| d) | Aggregated information - Volume - Price - Total |
11,308 £0.00 £0.00 |
| e) | Date of the transaction | 4 March 2022 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
7 March 2022
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBXGDXUXGDGDR
More from HIKMA Pharmaceuticals PLC
Transaction in Own Shares
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 15
Board/Management Information
2025
Dec 15
Major Shareholding Notification
2025
Nov 11
Director's Dealing
2025
Nov 11
Director's Dealing
2025
Nov 7
Earnings Release
2025
Nov 6
Major Shareholding Notification
2025
Oct 1
Director's Dealing
2025
Sep 23